Does ELTROMBOPAG OLAMINE Cause Product use in unapproved indication? 545 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 545 reports of Product use in unapproved indication have been filed in association with ELTROMBOPAG OLAMINE (ELTROMBOPAG). This represents 3.4% of all adverse event reports for ELTROMBOPAG OLAMINE.
545
Reports of Product use in unapproved indication with ELTROMBOPAG OLAMINE
3.4%
of all ELTROMBOPAG OLAMINE reports
157
Deaths
152
Hospitalizations
How Dangerous Is Product use in unapproved indication From ELTROMBOPAG OLAMINE?
Of the 545 reports, 157 (28.8%) resulted in death, 152 (27.9%) required hospitalization, and 30 (5.5%) were considered life-threatening.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ELTROMBOPAG OLAMINE. However, 545 reports have been filed with the FAERS database.
What Other Side Effects Does ELTROMBOPAG OLAMINE Cause?
Platelet count decreased (3,419)
Death (2,797)
Drug ineffective (1,117)
Platelet count increased (980)
Fatigue (868)
Headache (750)
Nausea (584)
Diarrhoea (558)
Malaise (516)
Contusion (420)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)
Which ELTROMBOPAG OLAMINE Alternatives Have Lower Product use in unapproved indication Risk?
ELTROMBOPAG OLAMINE vs ELUXADOLINE
ELTROMBOPAG OLAMINE vs ELVITEGRAVIR
ELTROMBOPAG OLAMINE vs EMAPALUMAB
ELTROMBOPAG OLAMINE vs EMAPALUMAB-LZSG
ELTROMBOPAG OLAMINE vs EMEND